The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Children Respiratory Syncytial Virus (RSV) Testing Market Research Report 2025
Synopsis
Children Respiratory Syncytial Virus (RSV) testing refers to the process of diagnosing respiratory syncytial virus infection in children. RSV is a common viral infection that affects the respiratory system, particularly in infants and young children. RSV testing helps to identify the presence of the virus in a child's respiratory samples, aiding in early diagnosis and appropriate management of the infection.
The global Children Respiratory Syncytial Virus (RSV) Testing market was valued at US$ 942.9 million in 2023 and is anticipated to reach US$ 179.5 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
This report aims to provide a comprehensive presentation of the global market for Children Respiratory Syncytial Virus (RSV) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Respiratory Syncytial Virus (RSV) Testing.
Report Scope
The Children Respiratory Syncytial Virus (RSV) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Children Respiratory Syncytial Virus (RSV) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Children Respiratory Syncytial Virus (RSV) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
OPERON
Laboratory Corporation of America
BioMerieux
Sekisui Diagnostics
Response Biomedical
ARUP Laboratories
DiaSorin (Focus Diagnostics)
Avellino
Becton, Dickinson, and Company
Novartis AG
Ortho Clinical Diagnostics
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
BIOMÉRIEUX
DiaSorin S.p.A.
Merck KGaA
Coris BioConcept
Siemens Healthcare S.A.
Quest Diagnostics Incorporated
Segment by Type
Testing Services
Testing Kits
Others
Segment by Application
Hospitals
POCT
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Children Respiratory Syncytial Virus (RSV) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Children Respiratory Syncytial Virus (RSV) testing refers to the process of diagnosing respiratory syncytial virus infection in children. RSV is a common viral infection that affects the respiratory system, particularly in infants and young children. RSV testing helps to identify the presence of the virus in a child's respiratory samples, aiding in early diagnosis and appropriate management of the infection.
The global Children Respiratory Syncytial Virus (RSV) Testing market was valued at US$ 942.9 million in 2023 and is anticipated to reach US$ 179.5 million by 2030, witnessing a CAGR of 9.7% during the forecast period 2024-2030.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
This report aims to provide a comprehensive presentation of the global market for Children Respiratory Syncytial Virus (RSV) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Respiratory Syncytial Virus (RSV) Testing.
Report Scope
The Children Respiratory Syncytial Virus (RSV) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Children Respiratory Syncytial Virus (RSV) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Children Respiratory Syncytial Virus (RSV) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
OPERON
Laboratory Corporation of America
BioMerieux
Sekisui Diagnostics
Response Biomedical
ARUP Laboratories
DiaSorin (Focus Diagnostics)
Avellino
Becton, Dickinson, and Company
Novartis AG
Ortho Clinical Diagnostics
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
BIOMÉRIEUX
DiaSorin S.p.A.
Merck KGaA
Coris BioConcept
Siemens Healthcare S.A.
Quest Diagnostics Incorporated
Segment by Type
Testing Services
Testing Kits
Others
Segment by Application
Hospitals
POCT
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Children Respiratory Syncytial Virus (RSV) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Testing Services
1.2.3 Testing Kits
1.2.4 Others
1.3 Market by Application
1.3.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Perspective (2019-2030)
2.2 Children Respiratory Syncytial Virus (RSV) Testing Growth Trends by Region
2.2.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Region (2019-2024)
2.2.3 Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Region (2025-2030)
2.3 Children Respiratory Syncytial Virus (RSV) Testing Market Dynamics
2.3.1 Children Respiratory Syncytial Virus (RSV) Testing Industry Trends
2.3.2 Children Respiratory Syncytial Virus (RSV) Testing Market Drivers
2.3.3 Children Respiratory Syncytial Virus (RSV) Testing Market Challenges
2.3.4 Children Respiratory Syncytial Virus (RSV) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Revenue
3.1.1 Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Revenue (2019-2024)
3.1.2 Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Children Respiratory Syncytial Virus (RSV) Testing Revenue
3.4 Global Children Respiratory Syncytial Virus (RSV) Testing Market Concentration Ratio
3.4.1 Global Children Respiratory Syncytial Virus (RSV) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Children Respiratory Syncytial Virus (RSV) Testing Revenue in 2023
3.5 Children Respiratory Syncytial Virus (RSV) Testing Key Players Head office and Area Served
3.6 Key Players Children Respiratory Syncytial Virus (RSV) Testing Product Solution and Service
3.7 Date of Enter into Children Respiratory Syncytial Virus (RSV) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Type
4.1 Global Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Type (2019-2024)
4.2 Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Type (2025-2030)
5 Children Respiratory Syncytial Virus (RSV) Testing Breakdown Data by Application
5.1 Global Children Respiratory Syncytial Virus (RSV) Testing Historic Market Size by Application (2019-2024)
5.2 Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size (2019-2030)
6.2 North America Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024)
6.4 North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size (2019-2030)
7.2 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024)
7.4 Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size (2019-2030)
8.2 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size (2019-2030)
9.2 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024)
9.4 Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size (2019-2030)
10.2 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.1.4 BD Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.1.5 BD Recent Development
11.2 Abbot (Alere)
11.2.1 Abbot (Alere) Company Detail
11.2.2 Abbot (Alere) Business Overview
11.2.3 Abbot (Alere) Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.2.4 Abbot (Alere) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.2.5 Abbot (Alere) Recent Development
11.3 Quidel
11.3.1 Quidel Company Detail
11.3.2 Quidel Business Overview
11.3.3 Quidel Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.3.4 Quidel Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.3.5 Quidel Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.4.4 Roche Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.5.4 Thermo Fisher Scientific Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Meridian Bioscience
11.6.1 Meridian Bioscience Company Detail
11.6.2 Meridian Bioscience Business Overview
11.6.3 Meridian Bioscience Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.6.4 Meridian Bioscience Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.6.5 Meridian Bioscience Recent Development
11.7 OPERON
11.7.1 OPERON Company Detail
11.7.2 OPERON Business Overview
11.7.3 OPERON Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.7.4 OPERON Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.7.5 OPERON Recent Development
11.8 Laboratory Corporation of America
11.8.1 Laboratory Corporation of America Company Detail
11.8.2 Laboratory Corporation of America Business Overview
11.8.3 Laboratory Corporation of America Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.8.4 Laboratory Corporation of America Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.8.5 Laboratory Corporation of America Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.9.4 BioMerieux Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Detail
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.10.4 Sekisui Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.11.4 Response Biomedical Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.11.5 Response Biomedical Recent Development
11.12 ARUP Laboratories
11.12.1 ARUP Laboratories Company Detail
11.12.2 ARUP Laboratories Business Overview
11.12.3 ARUP Laboratories Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.12.4 ARUP Laboratories Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.12.5 ARUP Laboratories Recent Development
11.13 DiaSorin (Focus Diagnostics)
11.13.1 DiaSorin (Focus Diagnostics) Company Detail
11.13.2 DiaSorin (Focus Diagnostics) Business Overview
11.13.3 DiaSorin (Focus Diagnostics) Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.13.4 DiaSorin (Focus Diagnostics) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.13.5 DiaSorin (Focus Diagnostics) Recent Development
11.14 Avellino
11.14.1 Avellino Company Detail
11.14.2 Avellino Business Overview
11.14.3 Avellino Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.14.4 Avellino Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.14.5 Avellino Recent Development
11.15 Becton, Dickinson, and Company
11.15.1 Becton, Dickinson, and Company Company Detail
11.15.2 Becton, Dickinson, and Company Business Overview
11.15.3 Becton, Dickinson, and Company Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.15.4 Becton, Dickinson, and Company Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.15.5 Becton, Dickinson, and Company Recent Development
11.16 Novartis AG
11.16.1 Novartis AG Company Detail
11.16.2 Novartis AG Business Overview
11.16.3 Novartis AG Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.16.4 Novartis AG Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.16.5 Novartis AG Recent Development
11.17 Ortho Clinical Diagnostics
11.17.1 Ortho Clinical Diagnostics Company Detail
11.17.2 Ortho Clinical Diagnostics Business Overview
11.17.3 Ortho Clinical Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.17.4 Ortho Clinical Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.17.5 Ortho Clinical Diagnostics Recent Development
11.18 Bio-Rad Laboratories, Inc.
11.18.1 Bio-Rad Laboratories, Inc. Company Detail
11.18.2 Bio-Rad Laboratories, Inc. Business Overview
11.18.3 Bio-Rad Laboratories, Inc. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.18.4 Bio-Rad Laboratories, Inc. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.18.5 Bio-Rad Laboratories, Inc. Recent Development
11.19 F. Hoffmann-La Roche Ltd.
11.19.1 F. Hoffmann-La Roche Ltd. Company Detail
11.19.2 F. Hoffmann-La Roche Ltd. Business Overview
11.19.3 F. Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.19.4 F. Hoffmann-La Roche Ltd. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.19.5 F. Hoffmann-La Roche Ltd. Recent Development
11.20 BIOMÉRIEUX
11.20.1 BIOMÉRIEUX Company Detail
11.20.2 BIOMÉRIEUX Business Overview
11.20.3 BIOMÉRIEUX Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.20.4 BIOMÉRIEUX Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.20.5 BIOMÉRIEUX Recent Development
11.21 DiaSorin S.p.A.
11.21.1 DiaSorin S.p.A. Company Detail
11.21.2 DiaSorin S.p.A. Business Overview
11.21.3 DiaSorin S.p.A. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.21.4 DiaSorin S.p.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.21.5 DiaSorin S.p.A. Recent Development
11.22 Merck KGaA
11.22.1 Merck KGaA Company Detail
11.22.2 Merck KGaA Business Overview
11.22.3 Merck KGaA Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.22.4 Merck KGaA Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.22.5 Merck KGaA Recent Development
11.23 Coris BioConcept
11.23.1 Coris BioConcept Company Detail
11.23.2 Coris BioConcept Business Overview
11.23.3 Coris BioConcept Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.23.4 Coris BioConcept Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.23.5 Coris BioConcept Recent Development
11.24 Siemens Healthcare S.A.
11.24.1 Siemens Healthcare S.A. Company Detail
11.24.2 Siemens Healthcare S.A. Business Overview
11.24.3 Siemens Healthcare S.A. Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.24.4 Siemens Healthcare S.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.24.5 Siemens Healthcare S.A. Recent Development
11.25 Quest Diagnostics Incorporated
11.25.1 Quest Diagnostics Incorporated Company Detail
11.25.2 Quest Diagnostics Incorporated Business Overview
11.25.3 Quest Diagnostics Incorporated Children Respiratory Syncytial Virus (RSV) Testing Introduction
11.25.4 Quest Diagnostics Incorporated Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
11.25.5 Quest Diagnostics Incorporated Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Testing Services
Table 3. Key Players of Testing Kits
Table 4. Key Players of Others
Table 5. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region (2019-2024)
Table 9. Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region (2025-2030)
Table 11. Children Respiratory Syncytial Virus (RSV) Testing Market Trends
Table 12. Children Respiratory Syncytial Virus (RSV) Testing Market Drivers
Table 13. Children Respiratory Syncytial Virus (RSV) Testing Market Challenges
Table 14. Children Respiratory Syncytial Virus (RSV) Testing Market Restraints
Table 15. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Players (2019-2024)
Table 17. Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Respiratory Syncytial Virus (RSV) Testing as of 2023)
Table 18. Ranking of Global Top Children Respiratory Syncytial Virus (RSV) Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Children Respiratory Syncytial Virus (RSV) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Children Respiratory Syncytial Virus (RSV) Testing Product Solution and Service
Table 22. Date of Enter into Children Respiratory Syncytial Virus (RSV) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Children Respiratory Syncytial Virus (RSV) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Children Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. BD Company Detail
Table 48. BD Business Overview
Table 49. BD Children Respiratory Syncytial Virus (RSV) Testing Product
Table 50. BD Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 51. BD Recent Development
Table 52. Abbot (Alere) Company Detail
Table 53. Abbot (Alere) Business Overview
Table 54. Abbot (Alere) Children Respiratory Syncytial Virus (RSV) Testing Product
Table 55. Abbot (Alere) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 56. Abbot (Alere) Recent Development
Table 57. Quidel Company Detail
Table 58. Quidel Business Overview
Table 59. Quidel Children Respiratory Syncytial Virus (RSV) Testing Product
Table 60. Quidel Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 61. Quidel Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Children Respiratory Syncytial Virus (RSV) Testing Product
Table 65. Roche Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Thermo Fisher Scientific Company Detail
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Children Respiratory Syncytial Virus (RSV) Testing Product
Table 70. Thermo Fisher Scientific Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Meridian Bioscience Company Detail
Table 73. Meridian Bioscience Business Overview
Table 74. Meridian Bioscience Children Respiratory Syncytial Virus (RSV) Testing Product
Table 75. Meridian Bioscience Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 76. Meridian Bioscience Recent Development
Table 77. OPERON Company Detail
Table 78. OPERON Business Overview
Table 79. OPERON Children Respiratory Syncytial Virus (RSV) Testing Product
Table 80. OPERON Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 81. OPERON Recent Development
Table 82. Laboratory Corporation of America Company Detail
Table 83. Laboratory Corporation of America Business Overview
Table 84. Laboratory Corporation of America Children Respiratory Syncytial Virus (RSV) Testing Product
Table 85. Laboratory Corporation of America Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 86. Laboratory Corporation of America Recent Development
Table 87. BioMerieux Company Detail
Table 88. BioMerieux Business Overview
Table 89. BioMerieux Children Respiratory Syncytial Virus (RSV) Testing Product
Table 90. BioMerieux Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 91. BioMerieux Recent Development
Table 92. Sekisui Diagnostics Company Detail
Table 93. Sekisui Diagnostics Business Overview
Table 94. Sekisui Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Product
Table 95. Sekisui Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 96. Sekisui Diagnostics Recent Development
Table 97. Response Biomedical Company Detail
Table 98. Response Biomedical Business Overview
Table 99. Response Biomedical Children Respiratory Syncytial Virus (RSV) Testing Product
Table 100. Response Biomedical Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 101. Response Biomedical Recent Development
Table 102. ARUP Laboratories Company Detail
Table 103. ARUP Laboratories Business Overview
Table 104. ARUP Laboratories Children Respiratory Syncytial Virus (RSV) Testing Product
Table 105. ARUP Laboratories Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 106. ARUP Laboratories Recent Development
Table 107. DiaSorin (Focus Diagnostics) Company Detail
Table 108. DiaSorin (Focus Diagnostics) Business Overview
Table 109. DiaSorin (Focus Diagnostics) Children Respiratory Syncytial Virus (RSV) Testing Product
Table 110. DiaSorin (Focus Diagnostics) Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 111. DiaSorin (Focus Diagnostics) Recent Development
Table 112. Avellino Company Detail
Table 113. Avellino Business Overview
Table 114. Avellino Children Respiratory Syncytial Virus (RSV) Testing Product
Table 115. Avellino Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 116. Avellino Recent Development
Table 117. Becton, Dickinson, and Company Company Detail
Table 118. Becton, Dickinson, and Company Business Overview
Table 119. Becton, Dickinson, and Company Children Respiratory Syncytial Virus (RSV) Testing Product
Table 120. Becton, Dickinson, and Company Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 121. Becton, Dickinson, and Company Recent Development
Table 122. Novartis AG Company Detail
Table 123. Novartis AG Business Overview
Table 124. Novartis AG Children Respiratory Syncytial Virus (RSV) Testing Product
Table 125. Novartis AG Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 126. Novartis AG Recent Development
Table 127. Ortho Clinical Diagnostics Company Detail
Table 128. Ortho Clinical Diagnostics Business Overview
Table 129. Ortho Clinical Diagnostics Children Respiratory Syncytial Virus (RSV) Testing Product
Table 130. Ortho Clinical Diagnostics Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 131. Ortho Clinical Diagnostics Recent Development
Table 132. Bio-Rad Laboratories, Inc. Company Detail
Table 133. Bio-Rad Laboratories, Inc. Business Overview
Table 134. Bio-Rad Laboratories, Inc. Children Respiratory Syncytial Virus (RSV) Testing Product
Table 135. Bio-Rad Laboratories, Inc. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 136. Bio-Rad Laboratories, Inc. Recent Development
Table 137. F. Hoffmann-La Roche Ltd. Company Detail
Table 138. F. Hoffmann-La Roche Ltd. Business Overview
Table 139. F. Hoffmann-La Roche Ltd. Children Respiratory Syncytial Virus (RSV) Testing Product
Table 140. F. Hoffmann-La Roche Ltd. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 141. F. Hoffmann-La Roche Ltd. Recent Development
Table 142. BIOMÉRIEUX Company Detail
Table 143. BIOMÉRIEUX Business Overview
Table 144. BIOMÉRIEUX Children Respiratory Syncytial Virus (RSV) Testing Product
Table 145. BIOMÉRIEUX Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 146. BIOMÉRIEUX Recent Development
Table 147. DiaSorin S.p.A. Company Detail
Table 148. DiaSorin S.p.A. Business Overview
Table 149. DiaSorin S.p.A. Children Respiratory Syncytial Virus (RSV) Testing Product
Table 150. DiaSorin S.p.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 151. DiaSorin S.p.A. Recent Development
Table 152. Merck KGaA Company Detail
Table 153. Merck KGaA Business Overview
Table 154. Merck KGaA Children Respiratory Syncytial Virus (RSV) Testing Product
Table 155. Merck KGaA Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 156. Merck KGaA Recent Development
Table 157. Coris BioConcept Company Detail
Table 158. Coris BioConcept Business Overview
Table 159. Coris BioConcept Children Respiratory Syncytial Virus (RSV) Testing Product
Table 160. Coris BioConcept Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 161. Coris BioConcept Recent Development
Table 162. Siemens Healthcare S.A. Company Detail
Table 163. Siemens Healthcare S.A. Business Overview
Table 164. Siemens Healthcare S.A. Children Respiratory Syncytial Virus (RSV) Testing Product
Table 165. Siemens Healthcare S.A. Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 166. Siemens Healthcare S.A. Recent Development
Table 167. Quest Diagnostics Incorporated Company Detail
Table 168. Quest Diagnostics Incorporated Business Overview
Table 169. Quest Diagnostics Incorporated Children Respiratory Syncytial Virus (RSV) Testing Product
Table 170. Quest Diagnostics Incorporated Revenue in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024) & (US$ Million)
Table 171. Quest Diagnostics Incorporated Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Type: 2023 VS 2030
Figure 3. Testing Services Features
Figure 4. Testing Kits Features
Figure 5. Others Features
Figure 6. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. POCT Case Studies
Figure 10. Others Case Studies
Figure 11. Children Respiratory Syncytial Virus (RSV) Testing Report Years Considered
Figure 12. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Children Respiratory Syncytial Virus (RSV) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Children Respiratory Syncytial Virus (RSV) Testing Market Share by Players in 2023
Figure 16. Global Top Children Respiratory Syncytial Virus (RSV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Respiratory Syncytial Virus (RSV) Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Children Respiratory Syncytial Virus (RSV) Testing Revenue in 2023
Figure 18. North America Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2019-2030)
Figure 20. United States Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2019-2030)
Figure 24. Germany Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Children Respiratory Syncytial Virus (RSV) Testing Market Share by Region (2019-2030)
Figure 32. China Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2019-2030)
Figure 40. Mexico Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Children Respiratory Syncytial Virus (RSV) Testing Market Share by Country (2019-2030)
Figure 44. Turkey Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Children Respiratory Syncytial Virus (RSV) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. BD Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 47. Abbot (Alere) Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 48. Quidel Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 51. Meridian Bioscience Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 52. OPERON Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 53. Laboratory Corporation of America Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 54. BioMerieux Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 55. Sekisui Diagnostics Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 56. Response Biomedical Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 57. ARUP Laboratories Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 58. DiaSorin (Focus Diagnostics) Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 59. Avellino Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 60. Becton, Dickinson, and Company Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 61. Novartis AG Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 62. Ortho Clinical Diagnostics Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 63. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 65. BIOMÉRIEUX Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 66. DiaSorin S.p.A. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 67. Merck KGaA Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 68. Coris BioConcept Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 69. Siemens Healthcare S.A. Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 70. Quest Diagnostics Incorporated Revenue Growth Rate in Children Respiratory Syncytial Virus (RSV) Testing Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
